Filing Flows › Quest Diagnostics (DGX) › Q2 2026 › vs Q1 2026
Quest Diagnostics (DGX) Q2 2026 vs Q1 2026 (quarter over quarter)
Quest Diagnostics's revenue rose $148M (+5%) from $2.9B in Q1 2026 to $3.0B in Q2 2026. The biggest changes: DIS business +$146M (+5%); All other operating segments +$2.0M (+3%). Operating margin 15.1% against 13.8% (+1.3 pts).
Quest Diagnostics, Q2 2026: revenue $3.0B (+10% year over year), operating margin 15.1%, net earnings $320M, operating cash flow $597M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Operating margin | 15.1% | 13.8% | +1.3 pts |
| Net margin | 10.5% | 8.7% | +1.8 pts |
| Free cash flow margin | 15.1% | 5.7% | +9.4 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| DIS business | $3.0B | $2.8B | $146M | +5% |
| All other operating segments | $65.0M | $63.0M | $2.0M | +3% |
| Revenue | $3.0B | $2.9B | $148M | +5% |
| Operating profit | $459M | $399M | $60.0M | +15% |
| Costs & expenses | $2.6B | $2.5B | $88.0M | +4% |
| Pre-tax earnings | $422M | $338M | $84.0M | +25% |
| Other expense, net | $37.0M | $61.0M | −$24.0M | -39% |
| Cost of revenue | $2.0B | $2.0B | $63.0M | +3% |
| SG&A | $529M | $504M | $25.0M | +5% |
| Other operating costs | $39.0M | $39.0M | $0 | 0% |
| Net earnings | $320M | $252M | $68.0M | +27% |
| Minority interests | $14.0M | $12.0M | $2.0M | +17% |
| Income tax | $88.0M | $74.0M | $14.0M | +19% |
| Depreciation & amortization | $146M | $147M | −$1.0M | -0.7% |
| Share-based compensation | $23.0M | $20.0M | $3.0M | +15% |
| Working capital & other | $108M | −$141M | $249M | — |
| Operating cash flow | $597M | $278M | $319M | +115% |
| Free cash flow (OCF − capex) | $459M | $164M | $295M | +180% |
| Capital expenditures | $138M | $114M | $24.0M | +21% |
Questions
How much did Quest Diagnostics's revenue grow quarter over quarter in Q2 2026?
Quest Diagnostics's revenue rose $148M (+5%) from $2.9B in Q1 2026 to $3.0B in Q2 2026.
What drove Quest Diagnostics's revenue change in Q2 2026?
DIS business +$146M (+5%); All other operating segments +$2.0M (+3%).